---
schema_version: "secwatch.filing_event.v1"
accession: "0001279569-23-001203"
form_type: "8-K"
ticker: null
cik: "0001633932"
company_name: "ESSA Pharma Inc."
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T14:52:05.885125+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# ESSA Pharma removes Class A preferred share rights from articles; no shares outstanding

## Summary
- Amended Articles of Incorporation on Sept 14, 2023 to remove special rights attached to Class A preferred shares.
- No Class A preferred shares are issued or outstanding.
- Amendment is a procedural cleanup; no impact on capital structure or voting rights.
- Amended articles filed as Exhibit 3.1 to the 8-K.

## SEC filing metadata
- accession: 0001279569-23-001203
- form_type: 8-K
- cik: 0001633932
- company_name: ESSA Pharma Inc.
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1633932/000127956923001203/0001279569-23-001203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1633932/000127956923001203/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001279569-23-001203
- JSON: https://secwatch.observer/filing/0001279569-23-001203.json
- Plain text: https://secwatch.observer/filing/0001279569-23-001203.txt

## Key facts
- Governance Changes
  ESSA Pharma Inc.: Removed special rights and restrictions on Class A preferred shares from Articles of Incorporation (effective 2023-09-14).
  - Change: charter amendment
  - Effective: 2023-09-14
  source text: On September 14, 2023, ESSA Pharma inc. (the “Company”) amended its Articles of Incorporation (the “Articles of Incorporation”) to remove the special rights and restrictions attached to the Class “A” preferred shares in the capital of the Company (none of which are issued and outstanding) under Article 30 of the Articles of Incorporation (the “Articles Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1633932/000127956923001203/0001279569-23-001203-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.